Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200217548> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4200217548 endingPage "925" @default.
- W4200217548 startingPage "919" @default.
- W4200217548 abstract "Bromide 1 - (β-phenylethyl)-4-amino-1,2,4-triazolium (Hypertril) has the properties of a beta-blocker and of NO-mimetic, is assigned to the IV class of toxicity. All these effects make Hypertril a promising drug for the treatment of cardiovascular diseases. The aim of this paper was to study the cardioprotective action of Hypertril in terms of the effect on the morpho-functional parameters of the myocardium in rats with experimental chronic heart failure (CHF). CHF was modeled on 80 white outbred rats weighing 190–220g by administering doxorubicin at a cumulative dose of 15 mg/kg. Hypertril and the reference drug metoprolol succinate were administered within 30 days after CHF modeling, intragastrically at doses of 3.5 mg/kg and 15 mg/kg. Morphometric analysis of the cellular structure of the myocardium was carried out on an Axioskop microscope (Zeiss, Germany), in an automatic mode using a macro program developed in a specialized programming environment VIDAS-2.5 (Kontron Elektronik, Germany). The administration of Hypertril to animals with CHF led to an increase in the density of nuclei of cardiomyocytes, the area of myocardiocyte nuclei, an increase in the nuclear cytoplasmic ratio and an increase in the concentration of RNA in the nuclei and cytoplasm of cardiomyocytes compared with the group of untreated animals, which indicated the presence of a pronounced cardioprotective effect in the drug candidate. In terms of such indicators as the density of surviving cardiomyocytes and the content of RNA in them, the nuclear-cytoplasmic ratio of Hypertril is significantly (p < 0.05) superior to metoprolol." @default.
- W4200217548 created "2021-12-31" @default.
- W4200217548 creator A5025070355 @default.
- W4200217548 creator A5041234323 @default.
- W4200217548 creator A5084420106 @default.
- W4200217548 creator A5086025334 @default.
- W4200217548 creator A5086438657 @default.
- W4200217548 date "2021-12-10" @default.
- W4200217548 modified "2023-09-26" @default.
- W4200217548 title "Morpho-functional indicators changes of rats’ myocardium in experimental doxorubicin-induced chronic heart failure and its pharmacological modulation with new 4-amino-1,2,4-triazole derivative" @default.
- W4200217548 cites W2037424126 @default.
- W4200217548 cites W2051363181 @default.
- W4200217548 cites W2053387643 @default.
- W4200217548 cites W2069982201 @default.
- W4200217548 cites W2076911700 @default.
- W4200217548 cites W2082191129 @default.
- W4200217548 cites W2084304742 @default.
- W4200217548 cites W2103588309 @default.
- W4200217548 cites W2164047272 @default.
- W4200217548 cites W2606264734 @default.
- W4200217548 cites W2937392638 @default.
- W4200217548 cites W3062364896 @default.
- W4200217548 cites W3132494856 @default.
- W4200217548 doi "https://doi.org/10.3897/pharmacia.68.e75298" @default.
- W4200217548 hasPublicationYear "2021" @default.
- W4200217548 type Work @default.
- W4200217548 citedByCount "2" @default.
- W4200217548 countsByYear W42002175482022 @default.
- W4200217548 countsByYear W42002175482023 @default.
- W4200217548 crossrefType "journal-article" @default.
- W4200217548 hasAuthorship W4200217548A5025070355 @default.
- W4200217548 hasAuthorship W4200217548A5041234323 @default.
- W4200217548 hasAuthorship W4200217548A5084420106 @default.
- W4200217548 hasAuthorship W4200217548A5086025334 @default.
- W4200217548 hasAuthorship W4200217548A5086438657 @default.
- W4200217548 hasBestOaLocation W42002175481 @default.
- W4200217548 hasConcept C111113717 @default.
- W4200217548 hasConcept C112705442 @default.
- W4200217548 hasConcept C126322002 @default.
- W4200217548 hasConcept C185592680 @default.
- W4200217548 hasConcept C190062978 @default.
- W4200217548 hasConcept C2776694085 @default.
- W4200217548 hasConcept C2778198053 @default.
- W4200217548 hasConcept C2780035454 @default.
- W4200217548 hasConcept C2781280847 @default.
- W4200217548 hasConcept C2781303535 @default.
- W4200217548 hasConcept C55493867 @default.
- W4200217548 hasConcept C71924100 @default.
- W4200217548 hasConcept C98274493 @default.
- W4200217548 hasConceptScore W4200217548C111113717 @default.
- W4200217548 hasConceptScore W4200217548C112705442 @default.
- W4200217548 hasConceptScore W4200217548C126322002 @default.
- W4200217548 hasConceptScore W4200217548C185592680 @default.
- W4200217548 hasConceptScore W4200217548C190062978 @default.
- W4200217548 hasConceptScore W4200217548C2776694085 @default.
- W4200217548 hasConceptScore W4200217548C2778198053 @default.
- W4200217548 hasConceptScore W4200217548C2780035454 @default.
- W4200217548 hasConceptScore W4200217548C2781280847 @default.
- W4200217548 hasConceptScore W4200217548C2781303535 @default.
- W4200217548 hasConceptScore W4200217548C55493867 @default.
- W4200217548 hasConceptScore W4200217548C71924100 @default.
- W4200217548 hasConceptScore W4200217548C98274493 @default.
- W4200217548 hasIssue "4" @default.
- W4200217548 hasLocation W42002175481 @default.
- W4200217548 hasLocation W42002175482 @default.
- W4200217548 hasLocation W42002175483 @default.
- W4200217548 hasOpenAccess W4200217548 @default.
- W4200217548 hasPrimaryLocation W42002175481 @default.
- W4200217548 hasRelatedWork W1978032370 @default.
- W4200217548 hasRelatedWork W1979757582 @default.
- W4200217548 hasRelatedWork W2024128476 @default.
- W4200217548 hasRelatedWork W2083949528 @default.
- W4200217548 hasRelatedWork W2332367370 @default.
- W4200217548 hasRelatedWork W2400461952 @default.
- W4200217548 hasRelatedWork W2754839811 @default.
- W4200217548 hasRelatedWork W2977907157 @default.
- W4200217548 hasRelatedWork W4210689174 @default.
- W4200217548 hasRelatedWork W79555446 @default.
- W4200217548 hasVolume "68" @default.
- W4200217548 isParatext "false" @default.
- W4200217548 isRetracted "false" @default.
- W4200217548 workType "article" @default.